Login to Your Account

Cytokinetics Files For IPO As Two Cancer Drugs Enter Clinic

By Karen Phil-Carey

Thursday, January 29, 2004
With hopes of raising $86.25 million to advance two cancer drugs and a preclinical candidate for heart failure, Cytokinetics Inc. filed for its initial public offering. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription